Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles.

Kensuke Ochi, Yataro Daigo, Toyomasa Katagiri, Satoshi Nagayama, Tatsuhiko Tsunoda, Akira Myoui, Norifumi Naka, Nobuto Araki, Ikuo Kudawara, Makoto Ieguchi, Yoshiaki Toyama, Junya Toguchida, Hideki Yoshikawa, Yusuke Nakamura

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

To establish a method for predicting the response to chemotherapy for osteosarcoma (OS), we performed expression profile analysis using cDNA microarray consisting of 23,040 genes. Hierarchical clustering based on the expression profiles of 19 biopsy samples of OS demonstrated two major clusters, one of which consisted exclusively of typical OS, i.e. conventional central OS in long bone of patients in the second decade. A set of genes was identified to characterize this subgroup, some of which have previously indicated some relation to carcinogenesis. Thirteen of the 19 patients were treated with an identical protocol of chemotherapy containing doxorubicin, cis-platinum and ifosfamide, and histological examination of resected specimens after operation classified 6 cases as responder and 7 as non-responder. A comparison of expression profiles of these two groups identified 60 genes whose expression levels were likely to be correlated with the response to chemotherapy (P<0.008). A drug response scoring (DRS) system was developed based on the expression levels of these genes, which proved to be applicable to predict the response to chemotherapy irrespective for the subclassification of OS. The reliability of the DRS system was further confirmed by testing additional 5 OS cases. These results indicated that scoring system based on gene-expression profiles might be useful to predict the response to chemotherapy for OS.

Original languageEnglish
Pages (from-to)647-655
Number of pages9
JournalInternational Journal of Oncology
Volume24
Issue number3
Publication statusPublished - 2004 Mar
Externally publishedYes

Fingerprint

Osteosarcoma
Transcriptome
Drug Therapy
Gene Expression
Ifosfamide
Oligonucleotide Array Sequence Analysis
Pharmaceutical Preparations
Doxorubicin
Cisplatin
Genes
Cluster Analysis
Carcinogenesis
Biopsy
Bone and Bones

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ochi, K., Daigo, Y., Katagiri, T., Nagayama, S., Tsunoda, T., Myoui, A., ... Nakamura, Y. (2004). Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles. International Journal of Oncology, 24(3), 647-655.

Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles. / Ochi, Kensuke; Daigo, Yataro; Katagiri, Toyomasa; Nagayama, Satoshi; Tsunoda, Tatsuhiko; Myoui, Akira; Naka, Norifumi; Araki, Nobuto; Kudawara, Ikuo; Ieguchi, Makoto; Toyama, Yoshiaki; Toguchida, Junya; Yoshikawa, Hideki; Nakamura, Yusuke.

In: International Journal of Oncology, Vol. 24, No. 3, 03.2004, p. 647-655.

Research output: Contribution to journalArticle

Ochi, K, Daigo, Y, Katagiri, T, Nagayama, S, Tsunoda, T, Myoui, A, Naka, N, Araki, N, Kudawara, I, Ieguchi, M, Toyama, Y, Toguchida, J, Yoshikawa, H & Nakamura, Y 2004, 'Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles.', International Journal of Oncology, vol. 24, no. 3, pp. 647-655.
Ochi K, Daigo Y, Katagiri T, Nagayama S, Tsunoda T, Myoui A et al. Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles. International Journal of Oncology. 2004 Mar;24(3):647-655.
Ochi, Kensuke ; Daigo, Yataro ; Katagiri, Toyomasa ; Nagayama, Satoshi ; Tsunoda, Tatsuhiko ; Myoui, Akira ; Naka, Norifumi ; Araki, Nobuto ; Kudawara, Ikuo ; Ieguchi, Makoto ; Toyama, Yoshiaki ; Toguchida, Junya ; Yoshikawa, Hideki ; Nakamura, Yusuke. / Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles. In: International Journal of Oncology. 2004 ; Vol. 24, No. 3. pp. 647-655.
@article{d0520604f68c4a92a0d792bdda89e562,
title = "Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles.",
abstract = "To establish a method for predicting the response to chemotherapy for osteosarcoma (OS), we performed expression profile analysis using cDNA microarray consisting of 23,040 genes. Hierarchical clustering based on the expression profiles of 19 biopsy samples of OS demonstrated two major clusters, one of which consisted exclusively of typical OS, i.e. conventional central OS in long bone of patients in the second decade. A set of genes was identified to characterize this subgroup, some of which have previously indicated some relation to carcinogenesis. Thirteen of the 19 patients were treated with an identical protocol of chemotherapy containing doxorubicin, cis-platinum and ifosfamide, and histological examination of resected specimens after operation classified 6 cases as responder and 7 as non-responder. A comparison of expression profiles of these two groups identified 60 genes whose expression levels were likely to be correlated with the response to chemotherapy (P<0.008). A drug response scoring (DRS) system was developed based on the expression levels of these genes, which proved to be applicable to predict the response to chemotherapy irrespective for the subclassification of OS. The reliability of the DRS system was further confirmed by testing additional 5 OS cases. These results indicated that scoring system based on gene-expression profiles might be useful to predict the response to chemotherapy for OS.",
author = "Kensuke Ochi and Yataro Daigo and Toyomasa Katagiri and Satoshi Nagayama and Tatsuhiko Tsunoda and Akira Myoui and Norifumi Naka and Nobuto Araki and Ikuo Kudawara and Makoto Ieguchi and Yoshiaki Toyama and Junya Toguchida and Hideki Yoshikawa and Yusuke Nakamura",
year = "2004",
month = "3",
language = "English",
volume = "24",
pages = "647--655",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles.

AU - Ochi, Kensuke

AU - Daigo, Yataro

AU - Katagiri, Toyomasa

AU - Nagayama, Satoshi

AU - Tsunoda, Tatsuhiko

AU - Myoui, Akira

AU - Naka, Norifumi

AU - Araki, Nobuto

AU - Kudawara, Ikuo

AU - Ieguchi, Makoto

AU - Toyama, Yoshiaki

AU - Toguchida, Junya

AU - Yoshikawa, Hideki

AU - Nakamura, Yusuke

PY - 2004/3

Y1 - 2004/3

N2 - To establish a method for predicting the response to chemotherapy for osteosarcoma (OS), we performed expression profile analysis using cDNA microarray consisting of 23,040 genes. Hierarchical clustering based on the expression profiles of 19 biopsy samples of OS demonstrated two major clusters, one of which consisted exclusively of typical OS, i.e. conventional central OS in long bone of patients in the second decade. A set of genes was identified to characterize this subgroup, some of which have previously indicated some relation to carcinogenesis. Thirteen of the 19 patients were treated with an identical protocol of chemotherapy containing doxorubicin, cis-platinum and ifosfamide, and histological examination of resected specimens after operation classified 6 cases as responder and 7 as non-responder. A comparison of expression profiles of these two groups identified 60 genes whose expression levels were likely to be correlated with the response to chemotherapy (P<0.008). A drug response scoring (DRS) system was developed based on the expression levels of these genes, which proved to be applicable to predict the response to chemotherapy irrespective for the subclassification of OS. The reliability of the DRS system was further confirmed by testing additional 5 OS cases. These results indicated that scoring system based on gene-expression profiles might be useful to predict the response to chemotherapy for OS.

AB - To establish a method for predicting the response to chemotherapy for osteosarcoma (OS), we performed expression profile analysis using cDNA microarray consisting of 23,040 genes. Hierarchical clustering based on the expression profiles of 19 biopsy samples of OS demonstrated two major clusters, one of which consisted exclusively of typical OS, i.e. conventional central OS in long bone of patients in the second decade. A set of genes was identified to characterize this subgroup, some of which have previously indicated some relation to carcinogenesis. Thirteen of the 19 patients were treated with an identical protocol of chemotherapy containing doxorubicin, cis-platinum and ifosfamide, and histological examination of resected specimens after operation classified 6 cases as responder and 7 as non-responder. A comparison of expression profiles of these two groups identified 60 genes whose expression levels were likely to be correlated with the response to chemotherapy (P<0.008). A drug response scoring (DRS) system was developed based on the expression levels of these genes, which proved to be applicable to predict the response to chemotherapy irrespective for the subclassification of OS. The reliability of the DRS system was further confirmed by testing additional 5 OS cases. These results indicated that scoring system based on gene-expression profiles might be useful to predict the response to chemotherapy for OS.

UR - http://www.scopus.com/inward/record.url?scp=6044270577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6044270577&partnerID=8YFLogxK

M3 - Article

C2 - 14767549

AN - SCOPUS:6044270577

VL - 24

SP - 647

EP - 655

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 3

ER -